NOCIL LimitedNOCILCorporate

Chemicals Latest results: Jun 2026 13 quarters of data
₹165.76
MCap ₹2,769 Cr · P/E 37.2
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹403 Cr
Sales · Jun 2026
+19.9% YoY
₹44 Cr
Operating Profit · Jun 2026
+50.1% YoY
11.0%
OPM % · Jun 2026
+25.0% YoY
₹27 Cr
Net Profit · Jun 2026
+64.8% YoY
₹1.64
EPS · Jun 2026
+65.7% YoY

📝 NOCIL Limited — results explained

Quarter ended June 2026 (Q1 FY27)

NOCIL Limited reported revenue of ₹403 crore for the quarter ended June 2026 (Q1 FY27), up 19.9% from ₹336 crore in the same quarter last year, and up 22.1% sequentially over the March 2026 quarter.

Net profit rose 64.8% year-on-year to ₹27 crore, from ₹17 crore. Earnings per share (EPS) came in at ₹1.64.

Operating profit stood at ₹44 crore — an operating margin (OPM) of 11.0%, compared with 8.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, NOCIL Limited posted revenue of ₹1,303 crore, a decline of 6.5% over FY25, with a net profit of ₹64 crore (down 40.2% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,370 crore with a net profit of ₹75 crore.

Valuation snapshot

At the current price of ₹165.76, NOCIL has a market capitalisation of ₹2,769 crore and a trailing P/E of about 37.2.

Within the Chemicals industry, it is the 25th-largest of the 79 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 33.76%, foreign institutional investors (FIIs) 5.28%, domestic institutional investors (DIIs) 6.96%, public shareholders 53.99% of NOCIL Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹2,769 Cr
Current Price ?
₹165.8
P/E ?
37.15above ind
Industry P/E ?
24.60
P/B ?
N/A
P/S ?
2.02
P/FCF ?
N/A
Enterprise Value ?
N/A
EV/EBITDA ?
N/A
PEG ?
N/A
Earnings Yield ?
2.7%
Dividend Yield ?
N/A
Profitability & Returns
Sales (TTM) ?
₹1,370 Cr
OPM ?
8.1%
Profit after tax (TTM) ?
₹75 Cr
EPS (TTM) ?
₹4.46
ROCE ?
N/A
ROE ?
N/A
ROA ?
N/A
Growth
Sales — latest qtr ?
₹403 Cr
PAT — latest qtr ?
₹27 Cr
YoY qtr sales growth ?
19.9%
YoY qtr profit growth ?
64.8%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
N/A
Debt to Equity ?
N/A
Interest Coverage ?
61.7
Current Ratio ?
N/A
Ownership
Promoter holding ?
33.76%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
1.9%
Return 6 months ?
-3.8%

🗓️ Quarterly results (13 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 397351341356372363318340336321316330403 +19.9% +22.1%
Operating Profit 54444843403724343021262044 +50.1% +122.0%
Other Income 556251091556169156 -9.3% -61.5%
Interest 0000010000000 -18.9% —
Depreciation 13131313131313131313141313 +0.4% +3.1%
Profit Before Tax 46364055363225252223162236 +64.1% +65.8%
Net Profit 34273041274119201717121827 +64.8% +51.8%
EPS 2.021.61—2.471.632.481.111.220.991.030.731.081.64 +65.7% +51.9%
OPM % 13.6% 12.5% 14.0% 12.1% 10.7% 10.2% 7.5% 10.0% 8.8% 6.5% 8.3% 6.1% 11.0% +25.0% +80.3%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1,393 Cr ₹1,303 Cr ₹1,370 Cr -6.5%
Operating Profit ₹135 Cr ₹97 Cr ₹112 Cr -28.1%
OPM % 9.66% 7.42% 8.14% -23.2%
NPM % 7.66% 4.89% 5.44% -36.2%
Other Income ₹39 Cr ₹46 Cr ₹46 Cr +20.0%
Depreciation ₹52 Cr ₹53 Cr ₹53 Cr +1.6%
Interest ₹2 Cr ₹1 Cr ₹1 Cr -62.4%
EBIT ₹83 Cr ₹44 Cr ₹59 Cr -46.9%
PBT ₹118 Cr ₹84 Cr ₹98 Cr -29.3%
Tax ₹16 Cr ₹10 Cr ₹13 Cr -36.7%
Net Profit ₹107 Cr ₹64 Cr ₹75 Cr -40.2%
EPS ₹6.44 ₹3.83 ₹4.48 -40.5%
Material Cost ₹405 Cr ₹353 Cr ₹432 Cr -12.8%
Employee Cost ₹48 Cr ₹45 Cr ₹48 Cr -5.7%
Extraordinary Items — ₹-5 Cr ₹-5 Cr —

👥 Shareholding (latest 2 periods)

Metric Jun 2026Sep 2026 % Chg
Promoters 33.76%33.76% +0.0%
FIIs 4.78%5.28% +10.5%
DIIs 7.47%6.96% -6.8%
Public 53.98%53.99% +0.0%
No. of Shareholders 1,61,3421,56,030 -3.3%

⚖️ Peer comparison

Industry: Chemicals · top 25 of 79 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 NAVINFLUOR Navin Fluorine ₹8,545.00 43,843 55.4 3,634 790 33.9% 21.7% 41.1% 130.1% 44.1% 107.7%
2 DEEPAKNTR Deepak Nitrite ₹1,596.00 21,768 27.8 8,575 784 15.5% 9.1% -4.8% -22.5% 36.4% 207.4%
3 DEEPAKFERT Deepak Fertilisers ₹1,323.00 16,718 17.0 12,103 985 16.7% 8.1% 12.0% -21.8% 22.5% 101.0%
4 TATACHEM Tata Chemicals ₹615.00 15,668 — 15,120 -1,971 11.3% -13.0% -2.0% -543.2% 14.4% -81.0%
5 PCBL PCBL Chemical ₹331.50 13,043 43.3 6,596 298 13.4% 4.5% -12.5% -46.0% 17.0% 64.8%
6 JUBLINGREA Jubilant Ingrevia ₹647.25 10,208 33.3 4,651 308 13.4% 6.6% 5.1% 10.3% 25.3% 40.9%
7 ALKYLAMINE Alkyl Amines ₹1,818.60 9,301 41.3 1,658 225 20.6% 13.5% -2.3% -3.8% 30.1% 93.1%
8 CLEAN Clean Science ₹820.00 8,715 37.4 982 232 35.7% 23.6% -2.5% -13.7% 21.9% -4.7%
9 GNFC Gujarat Narmada ₹539.75 7,931 7.6 8,410 1,037 14.8% 12.3% -1.5% 35.3% 39.8% 275.9%
10 GALAXYSURF Galaxy Surfactants ₹2,156.30 7,887 21.6 5,752 353 10.4% 6.1% 24.3% -50.0% 39.4% 108.7%
11 NEOGEN Neogen Chemicals ₹2,403.50 7,221 180.9 926 36 16.6% 3.8% 10.9% -17.6% 34.0% 66.8%
12 BALAMINES Balaji Amines ₹2,215.00 7,177 35.3 1,523 211 21.4% 13.9% 2.0% 6.5% 27.2% 113.9%
13 FCL Fineotex Chemical ₹53.07 6,180 41.6 1,012 148 16.7% 14.6% 44.8% 14.5% 174.8% 92.6%
14 ACI Archean Chemical ₹470.90 5,814 61.0 1,123 95 20.3% 8.5% 7.8% -37.0% 8.9% -24.4%
15 GULFOILLUB Gulf Oil ₹1,057.20 5,235 13.9 4,367 371 12.6% 8.5% 11.7% -3.4% 30.6% 27.0%
16 FOSECOIND Foseco India ₹6,846.50 5,186 64.7 618 77 17.5% 12.5% 12.2% -1.9% 9.2% 8.9%
17 GUJALKALI Gujarat Alkalies ₹696.50 5,115 77.0 4,497 66 11.2% 1.5% 7.0% 96.3% 12.6% 499.0%
18 LXCHEM Laxmi Organic ₹178.50 4,961 40.2 3,117 123 8.2% 4.0% -4.7% -43.4% 44.1% 194.8%
19 VISHNU Vishnu Chemicals ₹724.90 4,880 32.6 1,694 150 15.5% 8.8% 11.1% 12.2% 24.9% 23.0%
20 YASHO Yasho Industries ₹4,028.70 4,857 84.9 939 57 19.5% 6.1% 24.0% 771.1% 54.9% 801.3%
21 EPIGRAL Epigral ₹1,084.00 4,677 17.3 2,626 271 22.2% 10.3% -0.9% -7.2% 16.3% -37.9%
22 TATVA Tatva Chintan ₹1,867.60 4,369 85.0 556 51 19.3% 9.2% 32.6% 702.6% 42.8% 128.3%
23 GHCL GHCL ₹418.85 3,839 7.4 3,043 525 23.0% 17.3% -3.7% -23.5% -2.7% 31.8%
24 PREMEXPLN Premier Explosives ₹685.10 3,685 110.0 349 34 6.8% 9.6% -7.0% 60.5% -27.8% -80.2%
25 NOCIL NOCIL ₹187.02 3,124 47.2 1,370 66 8.4% 4.8% -6.5% -46.1% 19.9% 60.8%
❓ Frequently asked questions
What was NOCIL Limited's revenue in Q1 FY27?
NOCIL Limited reported revenue of ₹403 crore for the quarter ended June 2026 (Q1 FY27), up 19.9% from ₹336 crore in the same quarter last year, and up 22.1% sequentially over the March 2026 quarter.
What was NOCIL Limited's net profit in Q1 FY27?
Net profit rose 64.8% year-on-year to ₹27 crore, from ₹17 crore. Earnings per share (EPS) came in at ₹1.64.
What is NOCIL's market capitalisation and P/E ratio?
At the current price of ₹165.76, NOCIL has a market capitalisation of ₹2,769 crore and a trailing P/E of about 37.2.
Who owns NOCIL Limited? (shareholding pattern)
As of Sep 2026, promoters held 33.76%, foreign institutional investors (FIIs) 5.28%, domestic institutional investors (DIIs) 6.96%, public shareholders 53.99% of NOCIL Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI